scholarly journals Transient severe left ventricular dysfunction following percutaneous patent ductus arteriosus closure in an adult with bicuspid aortic valve: A case report

2016 ◽  
Vol 11 (3) ◽  
pp. 969-972 ◽  
Author(s):  
HUI-JEONG HWANG ◽  
KYUNG LIM YOON ◽  
IL SUK SOHN
Keyword(s):  
Case Report ◽  
Aortic Valve ◽  
Patent Ductus Arteriosus ◽  
Bicuspid Aortic Valve ◽  
Ventricular Dysfunction ◽  
Ductus Arteriosus ◽  
Left Ventricular ◽  
Severe Left Ventricular Dysfunction ◽  
Patent Ductus Arteriosus Closure ◽  
Patent Ductus

scholarly journals Prediction value of pulmonary hypertension in newly identified left ventricular dysfunction among adult patients after patent ductus arteriosus closure

2019 ◽  
Vol 9 (4) ◽  
pp. 204589401988842
Author(s):  
Peng-yuan Chen ◽  
Dong-ling Luo ◽  
He-zhi Li ◽  
Hong-wen Fei ◽  
Tao Huang ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Patent Ductus Arteriosus ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Ductus Arteriosus ◽  
Left Ventricular ◽  
Adult Patients ◽  
Post Procedure ◽  
Patent Ductus Arteriosus Closure ◽  
Patent Ductus

The present study aimed to propose the pulmonary hypertension for predicting left ventricular dysfunction in adults after patent ductus arteriosus closure. A total of 183 patients (age ≥18 years) after patent ductus arteriosus occlusion were retrospectively collected in this study. In brief, pre-, post-procedure and short-term follow-up transthoracic echocardiography were performed. Simpson’s method was used to measure the left ventricular ejection fraction (LVEF), and LVEF less than 50% after procedure was utilized as a criterion to identify left ventricular dysfunction. As a result, 36 (19.67%) patients developed newly identified left ventricular dysfunction. The rate of newly identified left ventricular dysfunction was significantly higher in moderate or severe pulmonary hypertension groups compared to the groups of mean pulmonary artery pressure (mPAP) <25 mmHg (P < .001). Logistic regression analysis showed that elevated mPAP ( ≥25 mmHg) was an independent predictive value for newly identified left ventricular dysfunction (OR = 3.584, 95%CI: 1.186–10.832, P = .024) after adjusting confounders. The ROC curve revealed a good discrimination power for predicting newly identified left ventricular dysfunction (AUC = 0.924, 95%CI: 0.885–0.963, P < .001). Taken together, newly identified left ventricular dysfunction after patent ductus arteriosus closure was prevalent in patients with elevated mPAP. The pre-procedure elevated mPAP is an independent risk factor for the prediction of the newly identified left ventricular dysfunction in adult patients undergoing percutaneous patent ductus arteriosus closure. It is feasible to propose a risk model for predicting post-procedure left ventricular dysfunction and a heart function monitoring in pulmonary hypertension patients.

Familial patent ductus arteriosus and bicuspid aortic valve with hand anomalies: A novel heart-hand syndrome

1999 ◽  
Vol 87 (2) ◽  
pp. 175-179 ◽  
Author(s):  
Bruce D. Gelb ◽  
Jian Zhang ◽  
Robert J. Sommer ◽  
Jared M. Wasserman ◽  
Milton J. Reitman ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Patent Ductus Arteriosus ◽  
Bicuspid Aortic Valve ◽  
Ductus Arteriosus ◽  
Hand Anomalies ◽  
Patent Ductus

scholarly journals MATR3 disruption in human and mouse associated with bicuspid aortic valve, aortic coarctation and patent ductus arteriosus

2015 ◽  
Vol 24 (8) ◽  
pp. 2375-2389 ◽  
Author(s):  
Fabiola Quintero-Rivera ◽  
Qiongchao J. Xi ◽  
Kim M. Keppler-Noreuil ◽  
Ji Hyun Lee ◽  
Anne W. Higgins ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Patent Ductus Arteriosus ◽  
Bicuspid Aortic Valve ◽  
Aortic Coarctation ◽  
Ductus Arteriosus ◽  
Human And Mouse ◽  
Patent Ductus
Sign in / Sign up

Export Citation Format

Share Document